Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

T Cell Types and Functions01:24

T Cell Types and Functions

2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Gene Therapy00:59

Gene Therapy

27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Integration of the naive pluripotency gene network with the response to GSK3 inhibition by Tcf7l1-driven enhancer decommissioning.

Stem cell reports·2026
Same author

Harmonizing standards and resources for the medical genome.

Nature·2026
Same author

Segmentation-free analysis of live-cell imaging data reveals how T cell modifications influence cancer cell aggregation dynamics.

Scientific reports·2026
Same author

Host Genetic Regulation of NLRP3 Inflammasome Cytokines Reveals Immune and Vascular Pathways in HIV.

medRxiv : the preprint server for health sciences·2026
Same author

Modeling and correction of SCID-X1 using CRISPR-Cas9 homology-directed repair in human HSPCs.

Molecular therapy. Nucleic acids·2026
Same author

Functional validation of <i>PIK3R1</i> variant causing activated phosphoinositide 3-kinase-δ syndrome 2 with hypogammaglobulinemia and bronchiectasis.

Journal of human immunity·2026

相关实验视频

Updated: Jan 9, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

2.2K

基因纠正调节性T细胞疗法用于IL2RA缺乏症.

Alvin S Ha1, Nechama Kalter2, Michael Rosenberg2

  • 1Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA 94158, USA.

Molecular therapy : the journal of the American Society of Gene Therapy
|December 11, 2025
PubMed
概括
此摘要是机器生成的。

基因纠正的调节性T细胞 (Tregs) 为IL2RA缺乏症,一种罕见的自身免疫性疾病提供了潜在的新疗法. 这种方法使用CRISPR-Cas9来修复基因突变,创建功能Tregs,比目前的选择更安全的治疗方法.

关键词:
克里斯普尔是什么意思?克里斯普尔是什么意思?这就是IL2RA.临床制造 临床制造 临床制造基因纠正 基因纠正免疫的先天错误 免疫的先天错误非病毒性非病毒性.罕见病是一种罕见的疾病.监管性T细胞是什么

更多相关视频

Generation of Induced Regulatory T Cells from Primary Human Na&#239;ve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.7K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.1K

相关实验视频

Last Updated: Jan 9, 2026

Generation of Human Chimeric Antigen Receptor Regulatory T Cells
10:29

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

2.2K
Generation of Induced Regulatory T Cells from Primary Human Na&#239;ve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.7K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.1K

科学领域:

  • 免疫学 免疫学 免疫学
  • 基因治疗 基因治疗
  • 细胞疗法细胞疗法

背景情况:

  • 双基IL2RA生殖系缺陷导致一种罕见的自身免疫性疾病,其特征是调节性T细胞 (Treg) 功能和互白素-2 (IL-2) 信号传递受损.
  • 目前的最终治疗方法,即全源性造血干细胞移植,涉及重大风险.

研究的目的:

  • 开发一种用于IL2RA缺乏症的新型治疗方法,使用ex vivo基因纠正自主Tregs (gcTregs).
  • 为个性化gCTreg疗法建立一个符合良好制造实践 (GMP) 的制造工艺.

主要方法:

  • 使用CRISPR-Cas9介导的同质导向修复来纠正来自患者的Tregs中的两种致病突变之一.
  • 基因校正旨在恢复IL2RA表达和Treg功能.
  • 开发和验证了临床规模的制造工艺.

主要成果:

  • 该gcTregs显示恢复IL2RA表达和强大的体外抑制活性.
  • 临床规模的制造实现了高效的基因校正和与健康的供体Tregs的功能等价性.
  • 该过程被证明是符合GMP的.

结论:

  • 与当前的选择相比,个性化gcTreg疗法代表了对IL2RA缺乏的潜在更安全的治疗方法.
  • 这种方法为治疗涉及Treg功能障碍的其他先天性免疫错误提供了一个框架.